Search research articles
Contact Us
Filters
Showing results (761-770 of 766) with videos related to
Page
of 77
Sort By:
You have reached the last page of results.
This site can display upto 766 results.
Journal of Medicinal Chemistry
|
August 1, 2015
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
Luc J Farmer, Mark W Ledeboer, Thomas Hoock, et al.
Journal of Medicinal Chemistry
|
July 15, 2014
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2
Michael P Clark, Mark W Ledeboer, Ioana Davies, et al.
Zeitschrift Fur Gerontologie Und Geriatrie
|
May 21, 2020
Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilities
Andreas H Jacobs, Kirsten Emmert, Ralf Baron, et al.
Acta Neuropathologica
|
April 29, 2023
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model
Ruizhi Deng, Eva Medico-Salsench, Anita Nikoncuk, et al.
Nature Reviews. Immunology
|
December 9, 2024
Neuroinflammation in Alzheimer disease
Michael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.
Acta Neuropathologica
|
December 11, 2019
Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases
Elena Perenthaler, Anita Nikoncuk, Soheil Yousefi, et al.
Page
of 77
Search research articles
Search
Showing results (761-770 of 766) with videos related to
Sort By:
Page
of 77
You have reached the last page of results.
This site can display upto 766 results.
Journal of Medicinal Chemistry
|
August 1, 2015
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
Luc J Farmer, Mark W Ledeboer, Thomas Hoock, et al.
Journal of Medicinal Chemistry
|
July 15, 2014
Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2
Michael P Clark, Mark W Ledeboer, Ioana Davies, et al.
Zeitschrift Fur Gerontologie Und Geriatrie
|
May 21, 2020
Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilities
Andreas H Jacobs, Kirsten Emmert, Ralf Baron, et al.
Acta Neuropathologica
|
April 29, 2023
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model
Ruizhi Deng, Eva Medico-Salsench, Anita Nikoncuk, et al.
Nature Reviews. Immunology
|
December 9, 2024
Neuroinflammation in Alzheimer disease
Michael T Heneka, Wiesje M van der Flier, Frank Jessen, et al.
Acta Neuropathologica
|
December 11, 2019
Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases
Elena Perenthaler, Anita Nikoncuk, Soheil Yousefi, et al.
Page
of 77